Annual Cash & Cash Equivalents
$76.73 M
-$53.46 M-41.06%
December 31, 2023
Summary
- As of February 24, 2025, TLIS annual cash & cash equivalents is $76.73 million, with the most recent change of -$53.46 million (-41.06%) on December 31, 2023.
- During the last 3 years, TLIS annual cash & cash equivalents has fallen by -$61.75 million (-44.59%).
- TLIS annual cash & cash equivalents is now -67.00% below its all-time high of $232.54 million, reached on December 31, 2021.
Performance
TLIS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$59.87 M
-$10.47 M-14.89%
June 30, 2024
Summary
- As of February 24, 2025, TLIS quarterly cash and cash equivalents is $59.87 million, with the most recent change of -$10.47 million (-14.89%) on June 30, 2024.
- Over the past year, TLIS quarterly cash and cash equivalents has stayed the same.
- TLIS quarterly cash and cash equivalents is now -82.80% below its all-time high of $348.01 million, reached on March 31, 2021.
Performance
TLIS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TLIS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.1% | 0.0% |
| 3 y3 years | -44.6% | 0.0% |
| 5 y5 years | +1012.9% | 0.0% |
TLIS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.0% | at low | -74.3% | at low |
| 5 y | 5-year | -67.0% | +255.2% | -82.8% | +177.1% |
| alltime | all time | -67.0% | +1012.9% | -82.8% | +177.1% |
Talis Biomedical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $59.87 M(-14.9%) |
| Mar 2024 | - | $70.34 M(-8.3%) |
| Dec 2023 | $76.73 M(-41.1%) | $76.73 M(-12.8%) |
| Sep 2023 | - | $88.00 M(-10.4%) |
| Jun 2023 | - | $98.20 M(-13.1%) |
| Mar 2023 | - | $112.96 M(-13.2%) |
| Dec 2022 | $130.19 M | $130.19 M(-9.5%) |
| Sep 2022 | - | $143.78 M(-13.1%) |
| Jun 2022 | - | $165.37 M(-11.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $187.59 M(-19.3%) |
| Dec 2021 | $232.54 M(+67.9%) | $232.54 M(-15.0%) |
| Sep 2021 | - | $273.60 M(-12.7%) |
| Jun 2021 | - | $313.46 M(-9.9%) |
| Mar 2021 | - | $348.01 M(+151.3%) |
| Dec 2020 | $138.48 M(+541.0%) | $138.48 M(+149.9%) |
| Sep 2020 | - | $55.41 M(+156.5%) |
| Dec 2019 | $21.60 M(+213.3%) | $21.60 M |
| Dec 2018 | $6.89 M | - |
FAQ
- What is Talis Biomedical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Talis Biomedical?
- What is Talis Biomedical annual cash & cash equivalents year-on-year change?
- What is Talis Biomedical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Talis Biomedical?
- What is Talis Biomedical quarterly cash and cash equivalents year-on-year change?
What is Talis Biomedical annual cash & cash equivalents?
The current annual cash & cash equivalents of TLIS is $76.73 M
What is the all time high annual cash & cash equivalents for Talis Biomedical?
Talis Biomedical all-time high annual cash & cash equivalents is $232.54 M
What is Talis Biomedical annual cash & cash equivalents year-on-year change?
Over the past year, TLIS annual cash & cash equivalents has changed by -$53.46 M (-41.06%)
What is Talis Biomedical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TLIS is $59.87 M
What is the all time high quarterly cash and cash equivalents for Talis Biomedical?
Talis Biomedical all-time high quarterly cash and cash equivalents is $348.01 M
What is Talis Biomedical quarterly cash and cash equivalents year-on-year change?
Over the past year, TLIS quarterly cash and cash equivalents has changed by $0.00 (0.00%)